Are you Dr. Wilfret?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 33 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Duke University Medical Ctr
Pediatric Bone Marrow Transplant
Durham, NC 27710Phone+1 919-668-1100- Is this information wrong?
Summary
- Dr. David Wilfret, MD is a pediatric infectious disease specialist in Durham, North Carolina. He is currently licensed to practice medicine in North Carolina.
Education & Training
Duke University HospitalFellowship, Pediatric Infectious Diseases, 2004 - 2007
Wake Forest University School of MedicineResidency, Pediatrics, 2002 - 2004
New York Medical College at St Vincent's Hospital and Medical Center of New YorkInternship, Transitional Year, 2001 - 2002
University of Florida College of MedicineClass of 2001
Certifications & Licensure
NC State Medical License 2002 - 2025- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Infectious Diseases
Clinical Trials
- Phase 3 Study of Reltecimod vs Placebo in Patients With Sepsis-associated Acute Kidney Injury Start of enrollment: 2018 May 24
Publications & Presentations
PubMed
- SARS-CoV-2 viral dynamics in a placebo-controlled phase 2 study of patients infected with the SARS-CoV-2 Omicron variant and treated with pomotrelvir.Borroto-Esoda, K., Tong, X., Plummer, A., Kearney, B., Kwong, A., Wilfret, D.> ;Microbiology Spectrum. 2024 Feb 6
- 1 citationsCharacterization of Pharmacokinetics, Biotransformation and Elimination of Pomotrelvir Orally Administered in Healthy Male Adults Using Two [C]-Labeled Microtracers wi...Ziping Yang, Shekman L Wong, David Cha, David Wilfret, David Turnquist, Andrew Plummer, Eric van Ingen, Brian P Kearney> ;Drug Metabolism and Disposition. 2023 Dec 1
- A comprehensive evaluation in clinic and physiologically-based pharmacokinetic modeling and simulation to confirm lack of cytochrome P450-mediated drug-drug interactio...Ziping Yang, Nathalie Rioux, Ludwig Vincent, Hannah M Jones, David Cha, Andrew Plummer, David Wilfret, Brian P Kearney> ;CPT. 2023 Oct 1
- Join now to see all
